Linforth R - Search Results

1

Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer.

Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C. Shaheed SU, et al. Among authors: linforth r. Clin Proteomics. 2018 Jan 11;15:3. doi: 10.1186/s12014-017-9179-4. eCollection 2018. Clin Proteomics. 2018. PMID: 29344009 Free PMC article. Review.

2

Identification of stage-specific breast markers using quantitative proteomics.

Shaheed SU, Rustogi N, Scally A, Wilson J, Thygesen H, Loizidou MA, Hadjisavvas A, Hanby A, Speirs V, Loadman P, Linforth R, Kyriacou K, Sutton CW. Shaheed SU, et al. Among authors: linforth r. J Proteome Res. 2013 Dec 6;12(12):5696-708. doi: 10.1021/pr400662k. Epub 2013 Oct 29. J Proteome Res. 2013. PMID: 24106833

3

Nipple aspirate fluid-A liquid biopsy for diagnosing breast health.

Shaheed SU, Tait C, Kyriacou K, Mullarkey J, Burrill W, Patterson LH, Linforth R, Salhab M, Sutton CW. Shaheed SU, et al. Among authors: linforth r. Proteomics Clin Appl. 2017 Sep;11(9-10):1700015. doi: 10.1002/prca.201700015. Epub 2017 Jun 26. Proteomics Clin Appl. 2017. PMID: 28488344 Free PMC article. Clinical Trial.

4

Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update.

Glassman D, Hignett S, Rehman S, Linforth R, Salhab M. Glassman D, et al. Among authors: linforth r. Anticancer Res. 2017 Oct;37(10):5329-5341. doi: 10.21873/anticanres.11959. Anticancer Res. 2017. PMID: 28982841 Review.

5

Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals.

Dandah O, Najafzadeh M, Isreb M, Linforth R, Tait C, Baumgartner A, Anderson D. Dandah O, et al. Among authors: linforth r. Mutat Res Genet Toxicol Environ Mutagen. 2018 Feb;826:41-46. doi: 10.1016/j.mrgentox.2017.12.001. Epub 2017 Dec 24. Mutat Res Genet Toxicol Environ Mutagen. 2018. PMID: 29412868

6

Using a Modified Lymphocyte Genome Sensitivity (LGS) test or TumorScan test to detect cancer at an early stage in each individual.

Anderson D, Najafzadeh M, Scally A, Jacob B, Griffith J, Chaha R, Linforth R, Soussaline M, Soussaline F. Anderson D, et al. Among authors: linforth r. FASEB Bioadv. 2018 Dec 20;1(1):32-39. doi: 10.1096/fba.1020. eCollection 2019 Jan. FASEB Bioadv. 2018. PMID: 32123810 Free PMC article.

7

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.

Bergamino MA, López-Knowles E, Morani G, Tovey H, Kilburn L, Schuster EF, Alataki A, Hills M, Xiao H, Holcombe C, Skene A, Robertson JF, Smith IE, Bliss JM, Dowsett M, Cheang MCU; POETIC investigators. Bergamino MA, et al. EBioMedicine. 2022 Sep;83:104205. doi: 10.1016/j.ebiom.2022.104205. Epub 2022 Aug 16. EBioMedicine. 2022. PMID: 35985932 Free PMC article.

8

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.

Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators. Cuzick J, et al. Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12. Lancet. 2014. PMID: 24333009 Free article. Clinical Trial.

9

Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer.

Chlebowski R, Cuzick J, Amakye D, Bauerfeind I, Buzdar A, Chia S, Cutuli B, Linforth R, Maass N, Noguchi S, Robidoux A, Verma S, Hadji P. Chlebowski R, et al. Among authors: linforth r. Breast. 2009 Aug;18 Suppl 2:S1-11. doi: 10.1016/S0960-9776(09)70002-5. Breast. 2009. PMID: 19712865 Free article. Review. No abstract available.

10

Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival.

Linforth R, Anderson N, Hoey R, Nolan T, Downey S, Brady G, Ashcroft L, Bundred N. Linforth R, et al. Clin Cancer Res. 2002 Oct;8(10):3172-7. Clin Cancer Res. 2002. PMID: 12374685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page